162 related articles for article (PubMed ID: 29095251)
1. Association between XRCC1 single-nucleotide polymorphism and acute radiation reaction in patients with nasopharyngeal carcinoma: A cohort study.
Chen H; Wu M; Li G; Hua L; Chen S; Huang H
Medicine (Baltimore); 2017 Nov; 96(44):e8202. PubMed ID: 29095251
[TBL] [Abstract][Full Text] [Related]
2. XRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patients.
Li H; You Y; Lin C; Zheng M; Hong C; Chen J; Li D; Au WW; Chen Z
Radiat Oncol; 2013 Feb; 8():31. PubMed ID: 23375119
[TBL] [Abstract][Full Text] [Related]
3. Acute oral mucositis in nasopharyngeal carcinoma patients treated with radiotherapy: association with genetic polymorphism in DNA DSB repair genes.
Ren JH; Dai XF; Yan GL; Jin M; Liu CW; Yang KY; Wu G; Ma CM
Int J Radiat Biol; 2014 Mar; 90(3):256-61. PubMed ID: 24350917
[TBL] [Abstract][Full Text] [Related]
4. Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy.
Zhai XM; Hu QC; Gu K; Wang JP; Zhang JN; Wu YW
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e125-32. PubMed ID: 23910235
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinoma.
Yu J; Huang Y; Liu L; Wang J; Yin J; Huang L; Chen S; Li J; Yuan H; Yang G; Liu W; Wang H; Pei Q; Guo C
Oncotarget; 2016 Dec; 7(50):82528-82537. PubMed ID: 27769064
[TBL] [Abstract][Full Text] [Related]
6. Single Nucleotide Polymorphisms in DNA Repair Genes (XRCC1, XRCC2, XRCC3) and Their Association with Radiotherapy Toxicity among Head and Neck Cancer Patients:A Study from South-Western Maharashtra.
Gudur AK; Gudur RA; Bhosale SJ; Kale SR; Datkhile KD
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3049-3057. PubMed ID: 37774056
[TBL] [Abstract][Full Text] [Related]
7. Distribution and haplotype associations of XPD Lys751Gln, XRCC1 Arg280His and XRCC1 Arg399Gln polymorphisms with nasopharyngeal carcinoma in the Malaysian population.
Visuvanathan S; Chong PP; Yap YY; Lim CC; Tan MK; Lye MS
Asian Pac J Cancer Prev; 2014; 15(6):2747-51. PubMed ID: 24761895
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population.
Cao Y; Miao XP; Huang MY; Deng L; Hu LF; Ernberg I; Zeng YX; Lin DX; Shao JY
BMC Cancer; 2006 Jun; 6():167. PubMed ID: 16796765
[TBL] [Abstract][Full Text] [Related]
9. The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinoma.
Guo C; Huang Y; Yu J; Liu L; Gong X; Huang M; Jiang C; Liao Y; Huang L; Yang G; Li J
Oncotarget; 2017 Apr; 8(15):25334-25344. PubMed ID: 28445979
[TBL] [Abstract][Full Text] [Related]
10. ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative radiotherapy for nasopharyngeal carcinoma.
Jin H; Xie X; Wang H; Hu J; Liu F; Liu Z; Zhou J; Zhang Y; Xi X; Hu B; Liao Y; Tang J
PLoS One; 2014; 9(7):e101256. PubMed ID: 25025378
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of XRCC1 Gene Polymorphism as a Biomarker in Head and Neck Cancer Patients Undergoing Chemoradiation Therapy.
Nanda SS; Gandhi AK; Rastogi M; Khurana R; Hadi R; Sahni K; Mishra SP; Srivastava AK; Bhatt MLB; Parmar D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):593-601. PubMed ID: 29893275
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of XRCC1 and XRCC2 DNA Repair genes and Interaction with Environmental Factors Influence the Risk of Nasopharyngeal Carcinoma in Northeast India.
Singh SA; Ghosh SK
Asian Pac J Cancer Prev; 2016; 17(6):2811-9. PubMed ID: 27356695
[TBL] [Abstract][Full Text] [Related]
13. Association between XRCC1 single-nucleotide polymorphisms and susceptibility to nasopharyngeal carcinoma: An update meta-analysis.
Lin J; Ye Q; Wang Y; Wang Y; Zeng Y
Medicine (Baltimore); 2018 Aug; 97(32):e11852. PubMed ID: 30095663
[TBL] [Abstract][Full Text] [Related]
14. Alterations in XRCC1 gene profile in pathogenesis of oral cavity cancer: A population-based study from Kamrup Urban District of Assam, India.
Borkotoky R; Malakar B; Saikia AK; Mukherjee SN; Bose S
Curr Probl Cancer; 2020 Feb; 44(1):100473. PubMed ID: 30954277
[TBL] [Abstract][Full Text] [Related]
15. Effect of nutritional status before radiotherapy on radiation-induced acute toxicities in patients with nasopharyngeal carcinoma.
Song X; Su L; Lin Q; Liu S; Zhang W; Hong J
Head Neck; 2023 Mar; 45(3):620-628. PubMed ID: 36600471
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
Chen JL; Huang YS; Kuo SH; Hong RL; Ko JY; Lou PJ; Wang CW
Oncotarget; 2017 Feb; 8(8):14068-14077. PubMed ID: 27764778
[TBL] [Abstract][Full Text] [Related]
17. Impact of polymorphisms in angiogenesis-related genes on clinical outcomes of radiotherapy in patients with nasopharyngeal carcinoma.
Ma WL; Liu R; Huang LH; Zou C; Huang J; Wang J; Chen SJ; Meng XG; Yang JK; Li H; Yang GP; Guo CX
Clin Exp Pharmacol Physiol; 2017 May; 44(5):539-548. PubMed ID: 28199751
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of DNA repair genes XRCC1 and LIG4 and idiopathic male infertility.
Ghasemi H; Khodadadi I; Fattahi A; Moghimbeigi A; Tavilani H
Syst Biol Reprod Med; 2017 Dec; 63(6):382-390. PubMed ID: 28991497
[TBL] [Abstract][Full Text] [Related]
19. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
